Industry Conference

NKGen Biotech is pioneering an immune therapy for neurodegeneration. But its true innovation may be a strategic pivot to Asia's fast-track regulatory pathways.

Starton Therapeutics heads to a key investor conference not with a new molecule, but a new method. Can their delivery tech turn old drugs into new blockbusters?

As Centuri Holdings prepares for a key investor conference, its new leadership team must address pressing margin concerns while pitching a long-term growth story.

At IBC2026, iodyne's deep partner integrations and Pro Mini debut signal a shift where robust, encrypted data handling is no longer optional but a core strategy.

As cars become computers on wheels, ECARX is vying for the driver's seat. A key investor pitch could define its trajectory in the crowded auto-tech race.

Beyond the crypto hype, stablecoins are maturing into critical infrastructure. As Singapore hosts the Stablecoin Summit, a look at how regulation is paving the way for a trillion-dollar market.

As its leaders head to Oppenheimer’s Fintech conference, we explore how MVB Financial built the resilient tech and regulatory backbone for today's top innovators.

With a key investor conference ahead, MacroGenics balances promising cancer drug data against a history of clinical setbacks and a major strategic pivot.

The role of payroll is transforming. PayrollOrg’s upcoming conference highlights a shift from processing pay to strategic leadership, technology, and global ops.

As AI fuels a new arms race in cyberspace, one firm is betting its future on a surprising strategy: face-to-face meetings. A look at why human connection is key.

Toronto has greenlit multiplexes to ease its housing crisis, but policy is just the start. Experts say the real test is execution, from financing to construction.

As Holley courts investors, it's shedding assets to focus on core performance. Can this leaner strategy win over Wall Street amid industry crosswinds?

As Norfolk Southern execs head to a key investor conference, all eyes are on their strategy for navigating economic currents and leveraging tech for growth.

New data reveals 74% of firms rely on a single person for critical assets. As expertise walks out the door, can 'Maintenance Intelligence' save us?

As Aktis Oncology presents at key investor conferences, it showcases a precision miniprotein platform and a major Eli Lilly deal in a booming market.

AI is rewriting the rules for how clients find lawyers. As search shifts to answers, firms must adapt their visibility and ethics or risk becoming invisible.

With Phase 3 data imminent and a new Nasdaq ticker, Helus Pharma is using a key investor conference to frame its novel therapies as the next frontier.

As Cardiol Therapeutics prepares for a key investor conference, it's not just a presentation; it's a test of its strategy to build a durable franchise in heart disease.

As Vertical Aerospace courts investors, its hybrid and defense pivots will be tested. Can it secure the capital needed to clear the runway to certification?

With a unique EU certification, this UK firm's dissolvable beads deliver targeted antibiotic combinations, promising to slash revision surgeries and redefine care.